Supernus Pharmaceuticals reported $31.77M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Abbott USD 13.44B 195M Jun/2025
ANI Pharmaceuticals USD 621.56M 1.26M Jun/2025
Aurora Cannabis CAD 101.63M 648K Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Canopy Growth CAD 327.8M 161.87M Jun/2025
Corcept Therapeutics USD 6.6M 6.6M Jun/2025
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Novo Nordisk 118.72B 61.75B Mar/2025
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025